VRCAVerrica Pharmaceuticals Inc.同业对比
Verrica Pharmaceuticals Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRCA本股 | $79M#7 | — | 18.2x#12 | 2.2x#2 | 370.2%#2 | 76.6%#1 | -34.2%#2 | -415.6%#13 | -36.1%#2 | — | -9.7%#1 | — |
| FBIO | — | 0.9x#1 | — | — | 9.7%#4 | 76.2%#2 | -111.0%#3 | 22.5%#1 | — | — | — | — |
| MAIA | $82M#1 | — | 3.9x#7 | — | — | 3.7%#4 | — | -108.3%#7 | — | — | — | — |
| OSTX | $81M#2 | — | — | — | — | -223.7%#16 | — | — | — | — | — | — |
| TELO | $80M#3 | — | 15.8x#10 | — | — | 37.0%#3 | — | -206.9%#11 | — | — | — | — |
| LFVN | $79M#6 | 15.8x#3 | 2.4x#5 | 0.4x#1 | -20.1%#5 | -48.3%#12 | 3.3%#1 | 15.1%#2 | 28.2%#1 | 6#1 | — | 3.0%#1 |
| CTOR | $80M#4 | — | 2.0x#4 | — | — | -17.1%#8 | — | -61.3%#3 | — | — | — | — |
| ACET | $79M#5 | — | 0.7x#1 | — | — | 0.3%#7 | — | -97.2%#6 | — | — | — | — |
| LNAI | $78M#8 | 1.1x#2 | — | 2390.9x#6 | -47.8%#6 | -101.3%#13 | -576678.5%#7 | — | — | 5#2 | — | — |
| LEXX | $78M#9 | — | 16.5x#11 | 110.6x#4 | 52.0%#3 | -105.4%#14 | -1683.0%#5 | -251.2%#12 | — | — | — | — |
| RNXT | $78M#10 | — | 8.7x#9 | 69.5x#3 | 2511.6%#1 | -26.7%#9 | -1114.0%#4 | -124.4%#9 | — | — | — | — |
| ACRV | $78M#11 | — | 0.9x#2 | — | — | 3.3%#5 | — | -89.9%#4 | — | — | — | — |
| GANX | $75M#12 | — | 6.6x#8 | 1360.4x#5 | -58.4%#7 | 1.2%#6 | -33908.5%#6 | -178.5%#10 | — | — | — | — |
| CING | $74M#13 | — | 3.1x#6 | — | — | -35.6%#11 | — | -95.7%#5 | — | — | — | — |
| SKYE | $73M#14 | — | — | — | — | -110.5%#15 | — | — | — | — | — | — |
| PMVP | $72M#15 | — | 1.0x#3 | — | — | -32.0%#10 | — | -108.7%#8 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议